Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Quantification and manipulation of brain estrogens
FY 2021-22
Summary
Steroid hormones are chemical messengers that are secreted by organs into the bloodstream. They are very important regulators of physiology and behavior. Estrogens are sex steroids that can be produced in the brain, where they are involved in many important functions and may help protect against Alzheimers disease. Estrogen levels vary among brain regions, so the development of a robust and accurate way to measure estrogens in discrete regions is of the utmost importance. Even a miniscule amount of estrogen can produce profound effects in target tissues, but current methods are not sensitive enough to detect very low levels in the brain. Our lab has already developed a sophisticated method of measuring estrogens in the avian brain using liquid chromatography tandem mass spectrometry. The main goal of this project is to optimize this method for use in rats, which are an excellent model for many aspects of human health and behavior. Our assay could be of great benefit for measuring estrogens in populations where it has been difficult to do so, including women receiving aromatase inhibitors as a treatment for breast cancer. After validating the use of our method in rats, we will use it to test the effectiveness of the drug DHED in delivering estrogen exclusively to the brain. After administering DHED to rats, we will measure estrogens in the brain and compare them to levels in peripheral tissues. Although many neurological and psychiatric diseases are linked to abnormal changes in estrogen levels, there is currently no way to administer estrogen therapies specifically to the brain without causing harmful off-target effects elsewhere. This study could help develop better treatments for neurological and psychiatric deficits in patient populations with low brain estrogens.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
466495
Name
Liu Megan
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Quantification and manipulation of brain estrogens
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Brain; Breast Cancer; Estrogens; Hippocampus; Mass Spectrometry; Steroids
Abstract
Steroid hormones are chemical messengers that are secreted by organs into the bloodstream. They are very important regulators of physiology and behavior. Estrogens are sex steroids that can be produced in the brain, where they are involved in many important functions and may help protect against Alzheimers disease. Estrogen levels vary among brain regions, so the development of a robust and accurate way to measure estrogens in discrete regions is of the utmost importance. Even a miniscule amount of estrogen can produce profound effects in target tissues, but current methods are not sensitive enough to detect very low levels in the brain. Our lab has already developed a sophisticated method of measuring estrogens in the avian brain using liquid chromatography tandem mass spectrometry. The main goal of this project is to optimize this method for use in rats, which are an excellent model for many aspects of human health and behavior. Our assay could be of great benefit for measuring estrogens in populations where it has been difficult to do so, including women receiving aromatase inhibitors as a treatment for breast cancer. After validating the use of our method in rats, we will use it to test the effectiveness of the drug DHED in delivering estrogen exclusively to the brain. After administering DHED to rats, we will measure estrogens in the brain and compare them to levels in peripheral tissues. Although many neurological and psychiatric diseases are linked to abnormal changes in estrogen levels, there is currently no way to administer estrogen therapies specifically to the brain without causing harmful off-target effects elsewhere. This study could help develop better treatments for neurological and psychiatric deficits in patient populations with low brain estrogens.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Liu, Megan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~